Nicotinic acid and nicotinamide: a review of their use for hyperphosphatemia in dialysis patients.
about
Niacin as a drug repositioning candidate for hyperphosphatemia management in dialysis patientsThe molecular biology and pathophysiology of vascular calcification.Effect of low dose nicotinic acid on hyperphosphatemia in patients with end stage renal disease.Nicotinic acid and related compounds: A meta-analysis of their use for hyperphosphatemia in dialysis patients.
P2860
Nicotinic acid and nicotinamide: a review of their use for hyperphosphatemia in dialysis patients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Nicotinic acid and nicotinamid ...... phatemia in dialysis patients.
@en
type
label
Nicotinic acid and nicotinamid ...... phatemia in dialysis patients.
@en
prefLabel
Nicotinic acid and nicotinamid ...... phatemia in dialysis patients.
@en
P2093
P2860
P356
P1433
P1476
Nicotinic acid and nicotinamid ...... phatemia in dialysis patients.
@en
P2093
Amanda Rennick
Brian Shepler
Lindsey Seel
Rabih Kalakeche
P2860
P304
P356
10.1002/PHAR.1258
P407
P577
2013-03-21T00:00:00Z